Pathophysiology of renal disease associated with liver disorders: Implications for liver transplantation. Part I.

被引:95
作者
Davis, CL
Gonwa, TA
Wilkinson, AH
机构
[1] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Med, Div Transplantat, Seattle, WA 98195 USA
[3] Mayo Clin, Transplant Ctr, Dept Med, Div Nephrol, Jacksonville, FL 32224 USA
[4] Mayo Clin, Transplant Ctr, Dept Med, Div Transplantat, Jacksonville, FL 32224 USA
[5] Univ Calif Los Angeles, Dept Med, Div Nephrol, Los Angeles, CA USA
[6] Univ Calif Los Angeles, Dept Med, Div Transplantat, Los Angeles, CA USA
关键词
D O I
10.1053/jlts.2002.31516
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Renal and hepatic function are often intertwined through both the existence of associated primary organ diseases and hemodynamic interrelationships. This connection occasionally results in the chronic failure of both organs, necessitating combined liver-kidney transplantation (LKT). Since 1988, more than 850 patients in the United States have received such transplants, with patient survival somewhat less than that for patients receiving either organ alone. Patients with renal failure caused by acute injury or hepatorenal syndrome have classically not been included as candidates for combined transplantation because of the reversibility of renal dysfunction after liver transplantation. However, the rate and duration of renal failure before liver transplantation is increasing in association with prolonged waiting list times. Thus, the issue of acquired permanent renal damage in the setting of hepatic failure continues to confront the transplant community. The following article and its sequel (Part II, to be published in vol 8, no 3 of this journal) attempt to review the problem of primary and secondary renal disease in patients with end-stage liver disease, elements involved in renal disease progression and recovery, the impact of renal disease on liver transplant outcome, and results of combined LKT; outline the steps in the pretransplantation renal evaluation; and provide the beginnings of an algorithm for making the decision for combined LKT.
引用
收藏
页码:91 / 109
页数:19
相关论文
共 219 条
  • [41] Molecular basis of renal fibrosis
    Eddy, AA
    [J]. PEDIATRIC NEPHROLOGY, 2000, 15 (3-4) : 290 - 301
  • [42] Low-dose vasopressin restores diuresis both in patients with hepatorenal syndrome and in anuric patients with end-stage heart failure
    Eisenman, A
    Armali, Z
    Enat, R
    Bankir, L
    Baruch, Y
    [J]. JOURNAL OF INTERNAL MEDICINE, 1999, 246 (02) : 183 - 190
  • [43] EKNOYAN G, 1988, KIDNEY LIVER DISEASE, P154
  • [44] EKNOYAN G, 1996, KIDNEY LIVER DIS, P123
  • [45] Severe alpha(1)-antitrypsin deficiency (PiZ homozygosity) with membranoproliferative glomerulonephritis and nephrotic syndrome, reversible after orthotopic liver transplantation
    Elzouki, AN
    Lindgren, S
    Nilsson, S
    Veress, B
    Eriksson, S
    [J]. JOURNAL OF HEPATOLOGY, 1997, 26 (06) : 1403 - 1407
  • [46] Features of Alagille syndrome in 92 patients: Frequency and relation to prognosis
    Emerick, KM
    Rand, EB
    Goldmuntz, E
    Krantz, ID
    Spinner, NB
    Piccoli, DA
    [J]. HEPATOLOGY, 1999, 29 (03) : 822 - 829
  • [47] Cyclosporine induces different responses in human epithelial, endothelial and fibroblast cell cultures
    Esposito, C
    Fornoni, A
    Cornacchia, F
    Bellotti, N
    Fasoli, G
    Foschi, A
    Mazzucchelli, I
    Mazzullo, T
    Semeraro, L
    Dal Canton, A
    [J]. KIDNEY INTERNATIONAL, 2000, 58 (01) : 123 - 130
  • [48] Fagerudd JA, 1997, KIDNEY INT, pS195
  • [49] FULMINANT HEPATIC-FAILURE IN NONMETASTATIC RENAL-CELL CARCINOMA
    FANG, JWS
    LAU, JYN
    WU, PC
    LAI, CL
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (03) : 474 - 477
  • [50] Feehally J, 1999, ANN MED INTERNE, V150, P91